XUCS:XETRA:XETRA-Xtrackers MSCI USA Consumer Staples UCITS (EUR)

ETF | Others |

Last Closing

USD 41.95

Change

+0.15 (+0.36)%

Market Cap

USD 0.09B

Volume

233.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.08 (+0.17%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.18%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.07 (+0.27%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.24 (-0.89%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.08 (+0.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.10 (+0.77%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.04 (+0.15%)

USD 79.79B

ETFs Containing XUCS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.61% 79% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.61% 79% B- 77% C+
Trailing 12 Months  
Capital Gain 12.12% 54% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.12% 53% F 55% F
Trailing 5 Years  
Capital Gain 37.86% 56% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.86% 54% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 6.89% 59% D- 58% F
Dividend Return 7.02% 59% D- 57% F
Total Return 0.13% 45% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 10.46% 58% F 67% D+
Risk Adjusted Return 67.13% 70% C- 73% C
Market Capitalization 0.09B 29% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.